What is Circadiance?
Circadiance is a prominent player in respiratory care, specializing in advanced remote patient monitoring solutions. The company's cloud-based technology is designed to strengthen the connection between healthcare providers and patients globally. Their innovative products, including various PAP devices, are crucial for managing sleep-disordered breathing and providing non-invasive ventilation for NICU patients. Circadiance's solutions are particularly impactful for premature infants, enabling them to transition home sooner, while simultaneously offering substantial time and cost savings for hospitals and homecare providers. The company targets healthcare institutions and professionals seeking cutting-edge monitoring technologies to improve patient outcomes and operational efficiency.
How much funding has Circadiance raised?
Circadiance has raised a total of $915K across 2 funding rounds:
Debt
$765K
Debt
$150K
Debt (2015): $765K, investors not publicly disclosed
Debt (2020): $150K led by PPP
Key Investors in Circadiance
PPP
Public-Private Partnership
What's next for Circadiance?
The recent major strategic investment signifies a pivotal moment for Circadiance, likely enabling the company to accelerate its product development, expand its market reach, and further enhance its remote patient monitoring capabilities. This capital infusion is expected to fuel growth initiatives, potentially including broader adoption of their PAP devices and cloud-based solutions within healthcare systems. Circadiance is well-positioned to capitalize on the increasing demand for telehealth and remote patient management technologies, aiming to solidify its leadership in the respiratory care market.
See full Circadiance company page
